http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107889509-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107889509-B |
| titleOfInvention | Methods and kits for molecular subtyping of bladder cancer |
| abstract | The present invention relates to an in vitro method for identifying molecular subtypes of tumors in bladder cancer patients, and a method for stratifying bladder cancer patients for tumor therapy. The present invention also relates to corresponding kits and uses thereof, as well as prognostic biomarkers for bladder cancer, especially single prognostic biomarkers. |
| priorityDate | 2015-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 538.